Brinker Capital Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.31M | Sell |
|
|||||
|
2025
Q2 | $4.02M | Buy |
|
|||||
|
2025
Q1 | $3.04M | Buy |
|
|||||
|
2024
Q4 | $3.54M | Sell |
|
|||||
|
2024
Q3 | $3.1M | Sell |
|
|||||
|
2024
Q2 | $3.74M | Sell |
|
|||||
|
2024
Q1 | $3.99M | Sell |
|
|||||
|
2023
Q4 | $3.95M | Sell |
|
|||||
|
2023
Q3 | $3.62M | Buy |
|
|||||
|
2023
Q2 | $15.3M | Sell |
|
|||||
|
2023
Q1 | $3.22M | Sell |
|
|||||
|
2022
Q4 | $3.93M | Sell |
|
|||||
|
2022
Q3 | $3.73M | Buy |
|
|||||
|
2022
Q2 | $3.27M | Buy |
|
|||||
|
2022
Q1 | $3.14M | Buy |
|
|||||
|
2021
Q4 | $2.3M | Sell |
|
|||||
|
2021
Q3 | $3.1M | Hold |
|
|||||
|
2021
Q2 | $3.1M | Buy |
|
|||||
|
2021
Q1 | $1.08M | Sell |
|
|||||
|
2020
Q4 | $5.27M | Buy |
|
|||||
|
2020
Q3 | $2.44M | Buy |
|